Loading…
Loading…
IQV · NYSE · Healthcare
“With a P/E of 20.9 against $7.91 earnings, IQVIA's valuation demands scrutiny of whether its healthcare data moat justifies this premium to intrinsic value.”
— In the voice of Graham
Analyze dividend yield, payout ratio, growth history, and sustainability for income-oriented investment decisions.
Market Cap
$28.39B
P/E Ratio
20.88
Forward P/E
—
EPS
$7.91
PEG Ratio
0.87
Book Value
$37.83
Dividend Yield
—
Profit Margin
8.34%
ROE
20.91%
Use the interactive dividend analyzer with pre-loaded data for IQVIA Holdings Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for IQV: